Ligand validation:4QJP

EDO: 1,2-ETHANEDIOL

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
4QJP_EDO_A_305	74%	87%	0.124	0.955	0.43	0.26	-	-	3	0	100%	1
4QJP_EDO_A_304	60%	64%	0.11	0.893	0.43	0.95	-	-	0	0	100%	1
4QJP_EDO_A_306	24%	72%	0.264	0.895	0.4	0.69	-	-	2	0	100%	1
4QJP_EDO_B_304	23%	40%	0.142	0.762	1.35	1.01	-	-	1	0	100%	1
4KNN_EDO_A_305	74%	26%	0.096	0.926	1.2	1.78	-	1	0	0	100%	1
4HU1_EDO_A_305	57%	55%	0.144	0.919	0.44	1.28	-	-	0	0	100%	1
6G5U_EDO_B_304	54%	66%	0.14	0.904	0.96	0.36	-	-	2	0	100%	1
6ANS_EDO_A_404	100%	89%	0.029	0.995	0.57	0.07	-	-	0	0	100%	1
4ITB_EDO_A_503	100%	88%	0.028	0.99	0.38	0.29	-	-	0	0	100%	1
4FQI_EDO_A_401	100%	85%	0.032	0.992	0.46	0.29	-	-	0	0	100%	1
4KXW_EDO_A_1003	100%	73%	0.033	0.993	0.64	0.4	-	-	0	0	100%	1
8JK3_EDO_A_304	100%	81%	0.033	0.992	0.22	0.58	-	-	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.